

With an unwavering commitment to scientific innovation, AccelBio's dedicated team embraced this opportunity to share their expertise and insights with an eager and curious audience. The event provided a unique platform for bridging the gap between science and the public, fostering a deeper understanding of the remarkable potential of 3D organoids in advancing healthcare.
We extend our gratitude to all those who attended and engaged with AccelBio during this event.